IP Library Assignment 075294/0821
Patent Assignment
Reel/Frame 075294/0821

Termination and Release of Security Interest in Patent Rights (Reel/Frame 69898/0380)

Recorded: 2026-03-27 Pages: 13
Assignor
JPMORGAN CHASE BANK, N.A.
Executed: 2026-03-23
Assignee
GENOMIC HEALTH, INC.
100 ABBOTT PARK ROAD, ABBOTT PARK, ILLINOIS, 60064-6001
Covered Properties (50)
Dna Methylation and Mutational Analysis Methods for Bladder Cancer Surveillance
Application: 18/130,547 →
Publication: US 2023/0374604
Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer
Application: 18/454,312 →
Publication: US 2024/0096451
Systems and Methods for Transferring Markings
Application: 18/290,902 →
Publication: US 2024/0331227
Universal Amplification of Fragmented Rna
Patent: 8,329,398 →
Application: 11/959,251 →
Publication: US 2009/0042192
Use of Intronic Rna to Measure Gene Expression
Patent: 7,767,391 →
Application: 10/783,884 →
Publication: US 2004/0191817
Gene Expression Markers for Breast Cancer Prognosis
Patent: 7,569,345 →
Application: 10/758,307 →
Publication: US 2004/0209290
Prediction of Likelihood of Cancer Recurrence
Patent: 7,723,033 →
Application: 11/345,611 →
Publication: US 2006/0286565
Expression Profile Algorithm and Test for Cancer Prognosis
Patent: 7,526,387 →
Application: 10/883,303 →
Publication: US 2005/0048542
Gene Expression Markers for Predicting Response to Chemotherapy
Patent: 7,871,769 →
Application: 11/102,228 →
Publication: US 2005/0260646
Gene Expression Markers for Predicting Response to Chemotherapy
Patent: 9,605,318 →
Application: 12/941,877 →
Publication: US 2011/0129833
Molecular Indicators of Breast Cancer Prognosis and Prediction of Treatment Response
Patent: 7,622,251 →
Application: 11/267,807 →
Publication: US 2006/0166231
Predicting Response to Chemotherapy Using Gene Expression Markers
Patent: 7,930,104 →
Application: 11/267,769 →
Publication: US 2006/0166230
Predicting Response to Chemotherapy Using Gene Expression Markers
Patent: 8,868,352 →
Application: 13/049,568 →
Publication: US 2011/0178374
Genes Involved Estrogen Metabolism
Patent: 7,888,019 →
Application: 11/731,196 →
Publication: US 2007/0275398
Genes Involved in Estrogen Metabolism
Patent: 8,906,625 →
Application: 12/971,874 →
Publication: US 2011/0275082
Genes Involved in Estrogen Metabolism
Patent: 8,808,994 →
Application: 12/972,148 →
Publication: US 2011/0275083
Gene Expression Markers for Colorectal Cancer Prognosis
Patent: 7,695,913 →
Application: 11/653,102 →
Publication: US 2009/0291434
Gene Expression Markers for Colorectal Cancer Prognosis
Patent: 8,153,378 →
Application: 12/696,934 →
Publication: US 2010/0190173
Gene Expression Markers for Colorectal Cancer Prognosis
Patent: 8,273,537 →
Application: 12/911,519 →
Publication: US 2011/0097759
Gene Expression Markers for Colorectal Cancer Prognosis
Patent: 8,153,379 →
Application: 12/911,526 →
Publication: US 2011/0039269
Gene Expression Markers for Colorectal Cancer Prognosis
Patent: 8,029,995 →
Application: 12/911,532 →
Publication: US 2011/0039270
Gene Expression Markers for Colorectal Cancer Prognosis
Patent: 8,153,380 →
Application: 12/911,544 →
Publication: US 2011/0039271
Gene Expression Markers for Colorectal Cancer Prognosis
Patent: 8,026,060 →
Application: 12/911,551 →
Publication: US 2011/0039272
Gene Expression Markers for Colorectal Cancer Prognosis
Patent: 8,198,024 →
Application: 13/009,733 →
Publication: US 2011/0111421
Gene Expression Markers for Colorectal Cancer Prognosis
Patent: 8,367,345 →
Application: 13/413,338 →
Publication: US 2012/0171688
Predictors of Patient Response to Treatment with Egf Receptor Inhibitors
Patent: 8,273,534 →
Application: 12/465,503 →
Publication: US 2009/0298701
Gene Expression Profile Algorithm and Test for Likelihood of Recurrence of Colorectal Cancer and Response to Chemotherapy
Application: 12/772,136 →
Publication: US 2010/0285980
Gene Expression Markers for Prediction of Patient Response to Chemotherapy
Patent: 8,067,178 →
Application: 12/404,268 →
Publication: US 2009/0305277
Methods of Predicting Cancer Risk Using Gene Expression in Premalignant Tissue
Patent: 8,765,383 →
Application: 12/755,368 →
Publication: US 2010/0291573
Gene Expression Markers for Prediction of Patient Response to Chemotherapy
Patent: 8,632,980 →
Application: 13/278,934 →
Publication: US 2012/0040842
Methods for Depleting Rna from Nucleic Acid Samples
Patent: 9,005,891 →
Application: 12/940,981 →
Publication: US 2011/0111409
Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer
Patent: 9,551,034 →
Application: 12/987,023 →
Publication: US 2011/0171633
Method for Quantitative Pcr Data Analysis System (Qdas)
Patent: 7,587,279 →
Application: 10/886,501 →
Publication: US 2006/0008809
Method and System to Characterize Transcriptionally Active Regions and Quantify Sequence Abundance for Large Scale Sequencing Data
Patent: 8,566,039 →
Application: 12/121,412 →
Publication: US 2009/0287420
Methods for Depleting Rna from Nucleic Acid Samples
Patent: 9,902,991 →
Application: 14/644,455 →
Publication: US 2015/0299771
Gene Fusions and Alternatively Spliced Junctions Associated with Breast Cancer
Application: 14/440,582 →
Publication: US 2015/0302143
Gene Expression Profile Algorithm for Calculating a Recurrence Score for a Patient with Kidney Cancer
Application: 14/779,428 →
Publication: US 2016/0048632
Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer
Application: 15/368,979 →
Publication: US 2017/0121780
Methods for Depleting Rna from Nucleic Acid Samples
Application: 15/866,840 →
Publication: US 2018/0208968
Systems and Methods for Pre-Analytical Substrate Processing
Application: 16/449,075 →
Publication: US 2019/0390252
Dna Methylation and Mutational Analysis Methods for Bladder Cancer Surveillance
Application: 16/612,926 →
Publication: US 2020/0165686
Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer
Application: 16/952,566 →
Publication: US 2021/0166790
Gene Expression Profile Algorithm for Calculating a Recurrence Score for a Patient with Kidney Cancer
Application: 17/086,850 →
Publication: US 2021/0151122
Gene Expression Markers for Breast Cancer Prognosis
Patent: 8,034,565 →
Application: 12/478,632 →
Publication: US 2010/0222229
Gene Expression Markers for Breast Cancer Prognosis
Patent: 8,206,919 →
Application: 13/221,549 →
Publication: US 2011/0312532
Gene Expression Markers for Breast Cancer Prognosis
Patent: 8,741,605 →
Application: 13/473,526 →
Publication: US 2012/0225433
Gene Expression Markers for Breast Cancer Prognosis
Patent: 9,944,990 →
Application: 14/257,723 →
Publication: US 2014/0287421
Gene Expression Markers for Breast Cancer Prognosis
Application: 15/897,617 →
Publication: US 2018/0230548
Gene Expression Profiling in Biopsied Tumor Tissues
Application: 11/450,896 →
Publication: US 2007/0141587
Prediction of Likelihood of Cancer Recurrence
Application: 15/674,817 →
Publication: US 2018/0051348
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 2, 2004
From: SCOTT, RANDY; BAKER, JOFFRE B.; KIEFER, MICHAEL C.
To: GENOMIC HEALTH
Reel/Frame 014684/0829 →
Assignment of Assignor's Interest May 31, 2005
From: COBLEIGH, MELODY A.
To: RUSH-PRESBYTERIAN-ST. LUKES MEDICAL CENTER
Reel/Frame 016292/0266 →
Assignment of Assignor's Interest May 31, 2005
From: SHAK, STEVE; BAKER, JOFFRE B.; CRONIN, MAUREEN T.
To: GENOMIC HEALTH, INC.
Reel/Frame 016292/0264 →
Assignment of Assignor's Interest Jul 18, 2005
From: BAKER, JOFFRE B.; BYANT, JOHN L.; PAIK, SOONMYUNG; SHAK, STEVEN
To: GENOMIC HEALTH, INC.; NSABP FOUNDATION, INC.
Reel/Frame 016544/0196 →
Assignment of Assignor's Interest Aug 1, 2005
From: BAKER, JOFFRE B.; SHAK, STEVEN
To: GENOMIC HEALTH, INC.
Reel/Frame 016598/0562 →
Assignment of Assignor's Interest Aug 1, 2005
From: GIANNI, LUCA
To: INSTITUTO NAZIONALE TUMORI
Reel/Frame 016598/0517 →
Assignment of Assignor's Interest Mar 23, 2006
From: TILSTON, CHRISTOPHER IAN; CHEERS, LAURENCE RICHARD
To: MICROSOFT CORPORATION
Reel/Frame 017352/0715 →
Assignment of Assignor's Interest Aug 31, 2006
From: BAKER, JOFFRE B.; BRYANT, JOHN L.; PAIK, SOONMYUNG; SHAK, STEVEN
To: GENOMIC HEALTH, INC.; NSABP FOUNDATION, INC.
Reel/Frame 018193/0533 →
Assignment of Assignor's Interest Aug 13, 2007
From: KIEFER, MICHAEL C.; BAKER, JOFFRE B.; HACKETT, JAMES
To: GENOMIC HEALTH, INC.
Reel/Frame 019683/0772 →
Change of Name Sep 16, 2008
From: COWENS, WAYNE; BAKER, JOFFRE; CLARK, KIM; HACKETT, JAMES
To: GENOMIC HEALTH, INC.
Reel/Frame 021533/0674 →
Corrective Assignment to Correct the Add Assignee: Nsabp Foundation, Inc. Four Allegheny Center, 5TH Floor Pittsburgh, Pennsylvania 15212 Previously Recorded on Reel 021533 Frame 0674. Assignor(S) Hereby Confirms the Nsabp Foundation, Inc. Four Allegheny Center, 5TH Floor Pittsburgh, Pennsylvania 15212. Sep 16, 2008
From: COWENS, WAYNE; BAKER, JOFFRE; CLARK, KIM; HACKETT, JAMES
To: GENOMIC HEALTH, INC.; NSABP FOUNDATION, INC.
Reel/Frame 021535/0979 →
Assignment of Assignor's Interest Nov 25, 2009
From: BAKER, JOFFRE B.; BRYANT, JOHN L.; PAIK, SOONMYUNG; SHAK, STEVEN
To: GENOMIC HEALTH, INC.; NSABP FOUNDATION, INC.
Reel/Frame 023572/0954 →
Change of Name Jan 14, 2010
From: RUSH-PRESBYTERIAN-ST. LUKE'S MEDICAL CENTER
To: RUSH UNIVERSITY MEDICAL CENTER
Reel/Frame 023788/0532 →
Assignment of Assignor's Interest Aug 5, 2010
From: KIEFER, MICHAEL C.; HOYT, KENNETH W.
To: GENOMIC HEALTH, INC.
Reel/Frame 024798/0429 →
Assignment of Assignor's Interest Sep 7, 2010
From: RUSH UNIVERSITY MEDICAL CENTER
To: GENOMIC HEALTH INC.,
Reel/Frame 024949/0543 →
Assignment of Assignor's Interest Sep 15, 2010
From: BAKER, JOFFRE B.; BRYANT, JOHN L.; PAIK, SOONMYUNG; SHAK, STEVEN
To: GENOMIC HEALTH, INC.; NSABP FOUNDATION, INC.
Reel/Frame 024994/0456 →
Assignment of Assignor's Interest Apr 28, 2011
From: KIEFER, MICHAEL C.; BAKER, JOFFRE B.; HACKETT, JAMES
To: GENOMIC HEALTH, INC.
Reel/Frame 026196/0057 →
Assignment of Assignor's Interest Apr 28, 2011
From: KIEFER, MICHAEL C.; BAKER, JOFFRE B.; HACKETT, JAMES
To: GENOMIC HEALTH, INC.
Reel/Frame 026196/0041 →
Assignment of Assignor's Interest Jun 10, 2011
From: BAKER, JOFFRE B.; BRYANT, JOHN L.; PAIK, SOONMYUNG; SHAK, STEVEN
To: GENOMIC HEALTH, INC.; NSABP FOUNDATION, INC.
Reel/Frame 026427/0431 →
Assignment of Assignor's Interest Aug 18, 2011
From: BAKER, JOFFRE B.; SHAK, STEVEN
To: GENOMIC HEALTH, INC.
Reel/Frame 026773/0764 →
Assignment of Assignor's Interest Aug 18, 2011
From: GIANNI, LUCA
To: ISTITUTO NAZIONALE TUMORI
Reel/Frame 026773/0725 →
Assignment of Assignor's Interest Dec 13, 2016
From: FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
To: GENOMIC HEALTH, INC.
Reel/Frame 040723/0393 →
Assignment of Assignor's Interest Nov 20, 2017
From: NSABP FOUNDATION, INC.
To: GENOMIC HEALTH, INC.
Reel/Frame 044179/0101 →
Assignment of Assignor's Interest Nov 29, 2017
From: NSABP FOUNDATION, INC.
To: GENOMIC HEALTH, INC.
Reel/Frame 044247/0167 →
Assignment of Assignor's Interest Jul 12, 2018
From: NSABP FOUNDATION, INC.
To: GENOMIC HEALTH, INC.
Reel/Frame 046331/0166 →